Akeso
Ivonescimab(Akeso)은 HER2 표적 항체로, Advanced Microsatellite Stable Colorectal Carcinoma; Metastatic Microsatellite Stable Colorectal Carcinoma 영역에서 개발·상용화 중입니다. 작용기전: target and bind to two distinct antigen. Phase 2에서 효능·안전성 신호를 검증 중입니다. ClinicalTrials.gov 기준 62건의 관련 임상이 등록되어 있습니다. 차별점: novel treatment option as first-line treatment in this patient group.
HER2
Advanced Microsatellite Stable Colorectal Carcinoma; Metastatic Microsatellite Stable Colorectal Carcinoma
Recruiting
Bispecific antibodies targeting programmed death 1 (PD-1) and vascular
govitecan), and chimeric antigen receptor (CAR) T
humanized IgG1 anti-VEGF monoclonal antibody
novel treatment option as first-line treatment in this patient group
target and bind to two distinct antigen
cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome, and on-target off-tumor effects r
PD-L1 expression
resistance to this initial chemoimmunotherapy, and there are limited effective treatment options available
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.
Akeso
Ivonescimab(Akeso)은 HER2 표적 항체로, Advanced Microsatellite Stable Colorectal Carcinoma; Metastatic Microsatellite Stable Colorectal Carcinoma 영역에서 개발·상용화 중입니다. 작용기전: target and bind to two distinct antigen. Phase 2에서 효능·안전성 신호를 검증 중입니다. ClinicalTrials.gov 기준 62건의 관련 임상이 등록되어 있습니다. 차별점: novel treatment option as first-line treatment in this patient group.
HER2
Advanced Microsatellite Stable Colorectal Carcinoma; Metastatic Microsatellite Stable Colorectal Carcinoma
Recruiting
Bispecific antibodies targeting programmed death 1 (PD-1) and vascular
govitecan), and chimeric antigen receptor (CAR) T
humanized IgG1 anti-VEGF monoclonal antibody
novel treatment option as first-line treatment in this patient group
target and bind to two distinct antigen
cytokine release syndrome, immune effector cell-associated neurotoxicity syndrome, and on-target off-tumor effects r
PD-L1 expression
resistance to this initial chemoimmunotherapy, and there are limited effective treatment options available
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.